 Hello, I am Dr. Bhush Bhatpayee, Head Department of Medical Oncology, Manipal Hospital, Dwarka, Delhi. I will be speaking today on personalized medicine and its usage in cancer. So personalized medicine is basically the right medicine for the right patient and at the right time. When I say that, I try to say that we are looking now and studying more of the genetic makeup of cancer, individual cancer and trying to target the various aspects of that particular cancer that the patient is having. So every cancer in every patient is different and therefore one size fits all approach is no more being practiced. We look into personalized tissues, the tissues are looked into and we look into the particular characteristics of those tissues. Those tissues are further analyzed by various molecular methods. The most common being used is next generation sequencing. This particular platform enables us to actually analyze the genetic material of cancer, individual cancer, the DNA of the cancer. And then according to the data which is available from this particular report, we analyze it. We discuss it in the background of the patient and the feasible keep the health of the patient and discuss each and every case in a tumor mode. Thereafter, we offer this targeted therapy to the patient we discuss. And to give you a certain examples, lung cancer in today's date can be also treated with a pill. You might not need a chemotherapy always for lung cancer. Some examples are for lung cancer, EGFR mutation, ALK mutation, ROS mutation. If these mutations are present, these actually cause cancer to progress. These are also called driver mutations. These mutations can be checked by oral tablets. Likewise, in breast cancer, you have certain subsets of breast cancer which are like estrogen positive, which can also be treated majorly by tablets only at times. You might not need a chemotherapy always. So please do discuss with your oncologist. Also, in breast cancer, a very important part is played by the presence of a HER2NE receptor. Targeted therapy is quite easily available and also is playing an important part in increasing the survival ability. So, why personalized medicine? Because the one-size-fits-all approach has now proven to be inferior in efficacy as compared to a targeted approach. And therefore, personalized medicine is here to stay. However, there are certain limitations with personalized medicine. And those limitations are an enormous amount of data which needs to be analyzed in a manner which your oncologist needs to analyze that particular data and choose a targeted therapy wisely for you. It might not always be feasible to provide a targeted therapy based on the data available. So, the limitations is also the availability of the drug. However, there are also certain compassionate basis programs which are there and one can actually arrange for a drug through these compassionate basis programs as well. So, that is how medical oncology has progressed and is actually benefiting patients in a big way. Thank you.